Omega Diagnostics Group (LON:ODX) Given Corporate Rating at FinnCap

Share on StockTwits

Omega Diagnostics Group (LON:ODX)‘s stock had its “corporate” rating reaffirmed by research analysts at FinnCap in a note issued to investors on Tuesday, ThisIsMoney.Co.Uk reports.

LON ODX opened at GBX 11.50 ($0.15) on Tuesday. Omega Diagnostics Group has a 12 month low of GBX 8.19 ($0.11) and a 12 month high of GBX 18 ($0.24). The stock has a market cap of $15.33 million and a price-to-earnings ratio of -2.21. The company’s 50 day moving average is GBX 9.86 and its two-hundred day moving average is GBX 11.17. The company has a current ratio of 1.82, a quick ratio of 1.18 and a debt-to-equity ratio of 3.80.

About Omega Diagnostics Group

Omega Diagnostics Group PLC, through its subsidiaries, develops, manufactures, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases and Other. The Allergy and Autoimmune segment engages in the research, development, production, and marketing of in-vitro allergy and autoimmune tests used by doctors to diagnose patients with allergies and autoimmune diseases.

See Also: What is a trade deficit?

Receive News & Ratings for Omega Diagnostics Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Diagnostics Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

RDI Reit  Receives Add Rating from Peel Hunt
RDI Reit Receives Add Rating from Peel Hunt
Liberum Capital Raises Team17 Group  Price Target to GBX 330
Liberum Capital Raises Team17 Group Price Target to GBX 330
SSE  Given “Neutral” Rating at UBS Group
SSE Given “Neutral” Rating at UBS Group
Newriver Reit  Receives Buy Rating from Peel Hunt
Newriver Reit Receives Buy Rating from Peel Hunt
Rentokil Initial  Price Target Raised to GBX 460
Rentokil Initial Price Target Raised to GBX 460
Royal Bank of Scotland Group  Given Hold Rating at Societe Generale
Royal Bank of Scotland Group Given Hold Rating at Societe Generale


© 2006-2019 Ticker Report